Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Bristol Myers to Acquire the Drugmaker Karuna for $14 Billion

The deal is a bet on the growing market for psychiatric and neurological drugs.

Lauren Hirsch
Author: Lauren Hirsch

Written by

Lauren Hirsch

in

Drugs (Pharmaceuticals), Food and Drug Administration, Karuna Therapeutics Inc, Mental Health and Disorders, Mergers, Acquisitions and Divestitures
←Trump Insists He’s ‘Not A Student Of Hitler’ While Defending ‘Poisoning The Blood’ Comments About Immigrants
Joe Rogan Corrected On His Own Show For Dissing Biden…By Quoting Trump→

More posts

  • Protesters, leaders push back against DHS over Newark detention facility conditions

  • Goldman and Lander spar hard over Israel

  • Snowflake climbs after Q1 results top expectations, guidance gets a boost

  • Synopsys drops despite better than expected Q2 results, big boost to full-year guidance

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube